Daclatasvir

Category: Hepatitis

Daclatasvir Overview

Daclatasvir, sold under the trade name Daklinza, is a medication used in combination with other medications to treat hepatitis C (HCV).[1] The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.[3] It is taken by mouth once a day.[1] Common side effects with sofusbivir and daclatasvir include headache, feeling tired, and nausea.[2&...

Read more Daclatasvir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daclatasvir

Recent Daclatasvir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Daclatasvir: (2 results)

Sorted by National Drug Code

• 0087-0213 DACLATASVIR DIHYDROCHLORIDE 30 mg by Bristol-myers Squibb Company
• 0087-0215 DACLATASVIR DIHYDROCHLORIDE 60 mg by Bristol-myers Squibb Company

Other drugs which contain Daclatasvir or a similar ingredient: (1 result)

• DAKLINZA Daclatasvir